Vivo Capital, LLC Rezolute, Inc. Transaction History
Vivo Capital, LLC
- $748 Million
- Q1 2024
A detailed history of Vivo Capital, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 2,797,704 shares of RZLT stock, worth $12 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
2,797,704
Previous 3,242,842
13.73%
Holding current value
$12 Million
Previous $3.21 Million
122.24%
% of portfolio
0.95%
Previous 0.39%
Shares
4 transactions
Others Institutions Holding RZLT
# of Institutions
33Shares Held
26.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$43.7 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.02MShares$13 Million0.5% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.6MShares$6.88 Million0.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$6.68 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.54MShares$6.61 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $167M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...